Department of Surgery

The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis (2017) Bergmann C, Brandt A, Merlevede B, Hallenberger L, Dees C, Wohlfahrt T, Pötter S, et al. Journal article Two Years of tranSMART in a University Hospital for Translational Research and Education (2017) Christoph J, Knell C, Naschberger E, Stürzl M, Maier C, Prokosch HU, Sedlmayr M Journal article Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis (2017) Fischer S, Rath T, Geppert CI, Manger B, Schett G, Neurath M, Atreya R Journal article Fraktionelle Flussreserve in der Diagnostik der koronaren Herzerkrankung: Klinische Bedeutung, Durchführung und Interpretation (2016) Möllmann H, Rudolph T, Rieber J, Eggebrecht H, Richardt G, Schmitz T, Werner N, Achenbach S Journal article The role of Signal Transducer and Activator of Transcription protein 5 (STAT5) in non-small cell lung cancer (NSCLC) (2016) Friedrich J, Heim L, Springel R, Mittler S, Gafencu D, Hartmann A, Sirbu H, Finotto S Conference contribution Jumonji Domain Containing Protein 3 (JMJD3) As a Novel Epigenetic Mechanism of Fibroblast Activation By Regulation of Fra-2 (2016) Bergmann C, Brandt A, Dees C, Zhang Y, Lin NY, Chen CW, Mallano T, et al. Conference contribution Dipeptidyl-Peptidase-4 (DPP4) Positive Fibroblast Subpopulation Promotes Fibrosis and Are a Molecular Target for Treatment of Fibrosis (2016) Soare A, Rauber S, Wohlfahrt T, Dees C, Liang R, Zhang Y, Chen CW, et al. Conference contribution Anatomy of the Transverse Colon and Possible Pathways of Aberrant Lymphatic Tumour Spread in Complete Mesocolic Excision for Colon Cancer (2016) Stelzner S, Hohenberger W, Weber K, West NP, Witzigmann H, Wedel T Conference contribution Response to 6 cycles of chemotherapy with FOLFIRINOX is predictive of overall survival in patients with locally advanced unresectable pancreatic cancer (2016) Haderlein M, Lubgan D, Lettmaier S, Semrau S, Wolf W, Golcher H, Hohenberger W, Fietkau R Conference contribution LOGIST - A local observational GIST registry: A non-interventional registry to observe patients with gastrointestinal stromal tumors (GIST) after R0/R1 resection - with or without adjuvant therapy with imatinib (CSTI571BDE77) - an interim analysis with 5 (2016) Reichardt P, Quietzsch D, Stuebs P, Cameron S, Gellert K, Wilhelm M, Killing B, et al. Conference contribution